Xanthene derived potent nonpeptidic inhibitors of recombinant human calpain I

Bioorganic and Medicinal Chemistry Letters

Volumn 6, Issue 13, 1996, Pages 1619-1622

  Chatterjee, Sankar ^a   Iqbal, Mohamed ^a   Kauer, James C ^a   Mallamo, John P ^a   Senadhi, Shobha ^a   Mallya, Satish ^a   Bozyczko Coyne, Donna ^a   Siman, Robert ^a  

^a CEPHALON INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALPASTATIN; RECOMBINANT CALPAIN 1 INHIBITOR; UNCLASSIFIED DRUG; XANTHENE DERIVATIVE;

ARTICLE; DRUG POTENCY; DRUG SYNTHESIS; ENZYME INHIBITION; ENZYME SPECIFICITY; INHIBITION KINETICS; NEUROMODULATION; STRUCTURE ANALYSIS;

EID: 0030576333     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-894X(96)00286-7     Document Type: Article

References (20)

1. 1. Wang, K. K. W.; Yuen, P. Trends Pharm. Sci. 1994, 15, 412.
2. 2. Croall, D. L.; DeMartino, G. N. Physiol. Rev. 1991, 71, 813.
3. 3. (a) Mehdi, S. Trends Biol. Sci. 1991, 16, 150;
4. (b) Harbeson, S. L.; Abelleira, S. M.; Akiyama, A.; Barrett, R., III,; Carroll, R. M.; Straub, J. A.; Tkacz, J. N.; Wu, C.; Musso, G. F. J. Med. Chem. 1994, 37, 2918;
5. (c) Li, Z.; Patil, G. S.; Golubski, Z. E.; Hori, H.; Tehrani, K.; Foreman, J. E.; Eveleth, D. D.; Bartus, R. T.; Powers, J. C. J. Med. Chem. 1993, 36, 3472.
6. 4. (a) Angliker, H.; Anagli, J.; Shaw, E. J. Med. Chem. 1992, 55, 216;
7. (b) Crawford, C.; Mason, R. W.; Wickstrom, P.; Shaw, E. Biochem. J. 1988, 255, 751;
8. (c) McGowan, E. B.; Backer, E.; Detwiler, T. C. Biochem. Biophys. Res. Commun. 1989, 158, 432;
9. (d) Huang, Z.; McGowan, E. B.; Detwiler, T. C. J. Med. Chem. 1992, 55, 2048;
10. (e) Harris, A. L.; Gregory, J. S.; Maycock, A. L.; Graybill,. T. L.; Osifo, I. K.; Schmidt, S. L.; Dolle, R. E. Bioorg. Med. Chem. Lett. 1995, 5, 393.
11. 5. Takahashi, K. In Intracellular Calcium-Dependent Proteolysis, Mellgren, R. L.; Murachi, T., Eds.; CRC Press: Boca Raton, 1991; pp 55-74.
12. 6. While this work was in progress, a series of quinolinecarboxamides were reported to be non-peptide inhibitors of human erythrocyte calpain I: Graybill, T. L.: Dolle, R. E.; Osifo, I. K.; Schmidt, S. L.; Gregory, J. S.; Harris, A. L.; Miller, M. S. Bioorg. Med. Chem. Lett., 1995, 5, 387.
13. 7. Hoffman, R. V.; Kim, H. Tetrahedron Lett. 1993, 34, 2051.
14. 8. Imperiali, B.; Abeles, R. H. Tetrahedron Lett. 1986, 27, 135.
15. 9. Revesz, L.; Briswalter, C.; Heng, R.; Leutwiler, A.; Mueller, R.; Wuethrich, H-J. Tetrahedron Lett. 1994, 35, 9693.
16. 10. Meyer, S. L.; Bozyczko-Coyne, D.; Mallya, S. K.; Spais, C. M.; Bihovsky, R.; Kawooya, J. K.; Lang, D. M.; Scott, R. W; Siman, R. Biochem. J. 1996, 314, 511.
17. m), correcting for the effect of substrate on the inactivation rate.
18. 12. Krantz, A.; Copp, L.J.; Coles, P.J.; Smith, R.A.; Heard, S.B. Biochemistry 1991, 30, 4678.
19. 13. Mehdi, S.; Angelastro, M. R.; Wiseman, J. S.; Bey, P. Biochem. Biophys. Res. Commun. 1988, 157, 1117.
20. 14. Chatterjee, S.; Josef, K.; Wells, G.; Iqbal, M.; Bihovsky, R.; Mallamo, J. P.; Ator, M. A.; Bozyczko-Coyne, D.; Mallya, S.; Senadhi, S.; Siman, S. Bioorg. Med. Chem. Lett. In press.